2011 annual financial data
Atossa Therapeutics 2011 Operating cash flow margin
Direct answer
Operating cash flow margin was -232,824.27%.
Operating income was -3,429,190 USD and net income was -3,442,269 USD.
Operating cash flow was -3,492,364 USD.
Get free Atossa Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,500 USD
- Operating income
- -3,429,190 USD
- Net income
- -3,442,269 USD
- Operating cash flow
- -3,492,364 USD